Reata marketwatch
Webb12 apr. 2024 · Larimar Therapeutics LRMR is a clinical-stage company making medicines for rare diseases. The company has a Zacks Rank #1 (Strong Buy).Here we dis... Webb26 feb. 2024 · Reata Pharmaceuticals (NASDAQ:RETA - Get Rating) had its target price increased by equities researchers at The Goldman Sachs Group from $115.00 to $117.00 in a research note issued to investors on Friday, Benzinga reports.The brokerage currently has a "buy" rating on the stock. The Goldman Sachs Group's target price points to a potential …
Reata marketwatch
Did you know?
Webb30 mars 2024 · Reata Pharmaceuticals, Inc. (RETA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. WebbExcited for Digital Asset Innovation Council's next meeting on Wednesday 4.19 -- focusing on the Catawba Digital Economic Zone and the regulation they have…
Webbför 11 timmar sedan · Trades from $ 1 Reata Pharmaceuticals, Inc. (RETA) Price Targets Enter Symbol Price Target Based on short-term price targets offered by 10 analysts, the … Webb6 apr. 2024 · Reata Pharmaceuticals - RETA News Today $92.19 -0.50 (-0.54%) (As of 04/6/2024 10:09 AM ET) Compare Today's Range $90.91 $93.51 50-Day Range $30.85 …
WebbIn the last trading session, 11.61 million shares of the Reata Pharmaceuticals Inc. (NASDAQ:RETA) were traded, and its beta was 1.19. Most recently the company’s share … Webb9 apr. 2024 · The share price of Reata Pharmaceuticals, Inc. (RETA) now What analysts predict: $113.7 52-week High/Low: $97.63 / $18.47 50/200 Day Moving Average: $66.0 / …
Webb8 nov. 2024 · Reata Pharmaceuticals, Inc. (RETA) delivered earnings and revenue surprises of 8.09% and 62.24%, ... the MarketWatch News staff is not involved in creating this …
WebbReata’s stock jumps 175% in premarket trading after FDA approval. 01 Mar 2024 13:08:45 haval.clWebbReata Pharmaceuticals Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for RETA All Analysts Top Analysts … boreal parkboreal parkaWebb1 mars 2024 · Reata Pharmaceuticals Inc.’s RETA, +0.40% stock was shooting up more than 170% in Wednesday morning action after the Food and Drug administration … haval clWebb11 apr. 2024 · According to analysts, Reata Pharmaceuticals's stock has a predicted upside of 100.25% based on their 12-month price targets. What analysts cover Reata … haval christchurch nzWebbI'm thrilled to announce that I've just completed J.P. Morgan's Virtual Experience Program in Investment Banking, where I gained practical skills in M&A… haval chitu south africaWebb13 apr. 2024 · A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … haval christchurch